Inhaled therapy reduces morning dips in asthma.

Author: ClarkT J, CochraneG M, HornC R

Paper Details 
Original Abstract of the Article :
14 asthmatic patients with nocturnal symptoms and morning dips in peak expiratory flow rate (PEFR) were treated with regular inhaled salbutamol for 1 or 2 weeks, followed by regular inhaled beclomethasone dipropionate, in addition to salbutamol, for a further 2 weeks. Mean PEFR rose to normal values...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/s0140-6736(84)91392-8

データ提供:米国国立医学図書館(NLM)

Inhaled Therapy: A Refreshing Oasis for Asthma Sufferers

Asthma, like a desert wind, can wreak havoc on the respiratory system, constricting airways and making it difficult to breathe. This study, like a beacon of hope, examines the potential of inhaled therapies to reduce morning dips in peak expiratory flow rate (PEFR), a common symptom of asthma.

The researchers studied 14 asthmatic patients with nocturnal symptoms and morning dips in PEFR. They found that regular inhaled therapy, like a refreshing oasis in the desert, significantly reduced morning dips in PEFR in 8 out of the 14 patients. This suggests that inhaled therapies can help alleviate a common symptom of asthma and improve patient quality of life.

Inhaled Therapy: A Key to Breathing Easier

This research highlights the effectiveness of inhaled therapies in managing asthma. By providing a direct route to the lungs, inhaled medications can target the underlying inflammation and improve airflow. This approach, like a well-worn path through the desert, can help patients navigate the challenges of asthma and breathe easier.

Managing Asthma: A Desert of Possibilities

This study underscores the importance of personalized treatment for asthma. Each patient may respond differently to various therapies, so finding the right combination is crucial. This research, like a compass guiding us through the desert, helps us understand the potential of inhaled therapies and develop more effective treatment strategies for managing asthma.

Dr. Camel's Conclusion

This study provides valuable insights into the management of asthma. Inhaled therapies offer a promising avenue for reducing morning dips in PEFR, a common symptom that can significantly impact patient quality of life. By understanding the diverse needs of asthma sufferers and exploring a range of treatment options, we can help them navigate the challenges of this chronic condition and breathe easier in a desert of possibilities.

Date :
  1. Date Completed 1984-07-09
  2. Date Revised 2019-06-11
Further Info :

Pubmed ID

6144875

DOI: Digital Object Identifier

10.1016/s0140-6736(84)91392-8

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.